TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
BioNordika (Sweden) AB
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
40,521
|
35,904
|
41,494 |
| Financial expenses |
0
|
0
|
1 |
| Earnings before taxes |
4,284
|
4,863
|
7,405 |
| EBITDA |
4,300
|
5,028
|
7,595 |
| Total assets |
10,432
|
13,408
|
16,856 |
| Current assets |
9,293
|
12,931
|
16,429 |
| Current liabilities |
6,982
|
10,150
|
13,320 |
| Equity capital |
3,450
|
3,258
|
3,537 |
| - share capital |
67
|
67
|
73 |
| Employees (average) |
14
|
13
|
12 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
33.1%
|
24.3%
|
21.0% |
| Turnover per employee |
2,894
|
2,762
|
3,458 |
| Profit as a percentage of turnover |
10.6%
|
13.5%
|
17.8% |
| Return on assets (ROA) |
41.1%
|
36.3%
|
43.9% |
| Current ratio |
133.1%
|
127.4%
|
123.3% |
| Return on equity (ROE) |
124.2%
|
149.3%
|
209.4% |
| Change turnover |
4,432
|
-2,229
|
1,874 |
| Change turnover % |
12%
|
-6%
|
5% |
| Chg. No. of employees |
1
|
1
|
2 |
| Chg. No. of employees % |
8%
|
8%
|
20% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.